Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Lutetium lu-177 vipivotide tetraxetan
Drug ID BADD_D02567
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID Not Available
MeSH ID C000610110
PubChem ID Not Available
TTD Drug ID Not Available
NDC Product Code Not Available
UNII G6UF363ECX
Synonyms 177Lu-PSMA-617 | 177Lu-617-prostate-specific membrane antigen ligand
Chemical Information
Molecular Formula Not Available
CAS Registry Number Not Available
SMILES Not Available
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Anaemia01.03.02.001-
Bone pain15.02.01.001-
Cholestasis09.01.01.001--
Death08.04.01.001-
Dry mouth07.06.01.002-
Pancytopenia01.03.03.003--
Prostate cancer metastatic16.25.01.002; 21.04.02.004--
Thrombocytopenia01.08.01.002--
General physical health deterioration08.01.03.018--
Malignant neoplasm progression16.16.01.005--
Prostate cancer16.25.01.001; 21.04.02.002--
Inflammation08.01.05.007; 10.02.01.089--
Ill-defined disorder08.01.03.049--
Disease progression08.01.03.038-
Cytopenia01.03.03.012--
Metastases to bone15.09.03.006; 16.22.02.005--
Hormone-refractory prostate cancer16.25.01.004; 21.04.02.007--
Illness08.01.03.091--
Myelosuppression01.03.03.015--
The 1th Page    1    Total 1 Pages